Delivery Order SPE2DB20D3303-SPE2DB24FY8S2
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,909.95 for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The contract has an ultimate completion date of December 23, 2024 and is a Firm Fixed Price contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,240.97 Firm Fixed Price Delivery Order contract is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The contract has an ultimate completion date of January 5, 2024 and was awarded on January 4, 2024. It is not designated as a set-aside contract. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,937.02, is for the delivery of 4564617016 - NITROFURANTOIN 25 MG/5 ML SUSP 230ML. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 16, 2024. The contract is not designated with any set-aside requirements. AmerisourceBergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,252.78, is for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of April 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
- The federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NITROFURANTOIN 25 MG/5 ML SUSP 240ML. The contract is a Delivery Order with a Firm Fixed Price valued at $2,574.74, with a completion date of December 19, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and the contract is a child of a larger Indefinite Delivery Contract (IDC)...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of the pharmaceutical product NITROFURANTOIN 25 MG/5 ML SUSP 230ML. The contract is a Delivery Order valued at $1,785.08 with a firm fixed price and an ultimate completion date of July 11, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp is the prime contractor for this award, which is part of a...
- This federal contract award, valued at $6,585.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565264514 - NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 29, 2024. This award is not associated with a set-aside designation. The...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,159.86 Firm Fixed Price Delivery Order contract provides for the supply of 4566188072 NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product. The award has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,719.71, is a delivery order for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 240ML, a pharmaceutical product. The contract has an ultimate completion date of April 10, 2025 and is a firm fixed price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type and a ceiling value of $5,747.27. It is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product, to support federal medical procurement needs, particularly for military and veteran healthcare systems. The contract is not...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB24FY8S2Delivery Order
This federal contract award, valued at $9,092.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NITROFURANTOIN 25 MG/5 ML SUSP 230ML, a pharmaceutical product, and is structured as a Delivery Order with a Firm Fixed Price pricing type. The contract has an ultimate completion date of February 1, 2024 and was awarded on January 31, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 1/31/24 |